Marianna Mancini's Sale of Viking Therapeutics, Inc. Common Stock

Marianna Mancini, an officer of Viking Therapeutics, Inc., has filed a Form 144 notice indicating the intent to sell 6,185 shares of common stock. The shares were acquired on October 27, 2025, as Performance Stock Units. The approximate sale date is set for October 28, 2025, with an aggregate market value of $216,491.70. The sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. There are no reported securities sold in the past three months.